PHILADELPHIA - March 25, 2013 - Dr. Daniel D.
Von Hoff, Physician-In-Chief of the Translational Genomics Research
Institute (TGen), is among the first class selected by the American
Association for Cancer Research for its newly formed Fellows of the
AACR Academy.
Dr. Von Hoff will be among those inaugurated to the Fellows of
the AACR Academy at the AACR Annual Meeting 2013, April 6-10 in
Washington, D.C.
The AACR Academy has been created to recognize and honor
distinguished scientists whose major scientific contributions have
propelled significant innovation and progress against cancer. These
Fellows have been selected through a rigorous peer review process
that evaluates individuals on the basis of their stellar scientific
achievements in cancer research.
"Our Board of Directors made the decision to establish the AACR
Academy as a mechanism for recognizing scientists whose
contributions to the cancer field have had an extraordinary impact.
Membership in the Fellows of the AACR Academy will be the most
prestigious honor bestowed by the American Association for Cancer
Research," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive
officer of the AACR.
The Fellows of the AACR Academy is as a separate entity within
the American Association for Cancer Research, and only individuals
who have made exceptional contributions to cancer and/or
cancer-related biomedical science are eligible for election.
The inaugural class of Fellows will be inducted into the AACR
Academy on Friday, April 5, 2013, at the National Museum of Women
in the Arts in Washington, D.C. at 6:30 p.m. Reporters who wish to
attend this dinner must RSVP to Jeremy Moore, associate director of
media relations at AACR, at jeremy.moore@aacr.org no later
than March 28.
The induction ceremony will be followed by a meeting of the
Academy on Saturday, April 6, and special recognition of the
inaugural Fellows during the opening plenary session on Sunday,
April 7, 2013. These events will be annual occurrences at future
AACR Annual Meetings.
The inaugural class of Fellows of the AACR Academy will consist
of 106 individuals, symbolizing the age of the organization upon
establishment of the Academy.
Future classes of Fellows shall consist of no more than 11
individuals, in honor of the 11 founding members of the American
Association for Cancer Research. These Fellows will be elected by
vote of all the Fellows of the AACR Academy.
The inaugural Fellows of the AACR Academy are:
Karen H. Antman, M.D., Provost, Boston University Medical
Campus; Dean, School of Medicine at Boston University
David Baltimore, Ph.D., Robert Andrews Millikan Professor of
Biology, President Emeritus at California Institute of
Technology
Françoise Barré-Sinoussi, Ph.D., Professor and Director,
Regulation of Retroviral Infections Unit, Virology Department at
the Institut Pasteur
Paul Berg, Ph.D., Director Emeritus, Department of Biochemistry
at Stanford University School of Medicine
Joseph R. Bertino, M.D. Chief Scientific Officer; Co-Leader,
Cancer Pharmacology and Preclinical Therapeutics Research Program
at The Cancer Institute of New Jersey; and University Professor of
Medicine and Pharmacology at UMNDJ-Robert Wood Johnson Medical
School
J. Michael Bishop, M.D., Professor and Director, The G.W.
Hooper Foundation at UCSF
Mina J. Bissell, Ph.D., Distinguished Scientist and Director,
Life Sciences Division at Lawrence Berkeley National
Laboratory
Elizabeth H. Blackburn, Ph.D., Morris Herzstein Endowed Chair
in Biology & Physiology; Professor, Departments of
Biochemistry/Biophysics and Microbiology/Immunology at UCSF
Sydney Brenner, MB.BCh., D. Phil., Founder, Acidophil, LLC;
Distinguished Professor, Salk Institute
Angela H. Brodie, Ph.D., Professor of Pharmacology, University
of Maryland School of Medicine, and Investigator, University of
Maryland Marlene and Stewart Greenebaum Cancer Center
Mario R. Capecchi, Ph.D., Distinguished Professor of Human
Genetics at the University of Utah
Webster K. Cavenee, Ph.D., Director, Ludwig Institute for
Cancer Research San Diego; Distinguished Professor, University of
California at San Diego
Martin Chalfie, Ph.D., William R. Kenan, Jr. Professor of
Biological Sciences; Chair, Department of Biological Sciences at
Columbia University
Zhu Chen, Ph.D., Minister of Health at the Ministry of Health
of the People's Republic of China
Aaron J. Ciechanover, M.D., D.Sc., Distinguished Research
Professor at Technion-Israel Institute of Technology
Bayard D. Clarkson, M.D., Member and Head, Laboratory of
Hematopoietic Cell Kinetics at Memorial Sloan-Kettering Cancer
Center
Donald S. Coffey, Ph.D., Catherine Iola and J. Smith Michael
Distinguished Professor of Urology at Johns Hopkins University
School of Medicine
Stanley N. Cohen, M.D., Kwoh-Ting Li Professor of Genetics and
Professor of Medicine at Stanford University School of
Medicine
Suzanne Cory, Ph.D., Research Professor, Molecular Genetics of
Cancer Division; Vice-Chancellor's Fellow Walter & Eliza Hall
Institute of Medical Research; The University of Melbourne
Carlo M. Croce, M.D., Professor and Chair, Department of
Molecular Virology, Immunology and Medical Genetics at The Ohio
State University Comprehensive Cancer Center
Tom Curran, Ph.D., Deputy Scientific Director, Division of
Cancer Pathobiology Children's Hospital of Philadelphia Research
Institute
Brian J. Druker, M.D., Director, JELD-WEN; Chair of Leukemia
Research and Investigator at OHSU Knight Cancer Institute; Oregon
Health & Science University; Howard Hughes Medical
Institute
Raymond N. DuBois, M.D., Ph.D., Executive Director, Biodesign
Institute at Arizona State University
Sir Martin J. Evans, Ph.D., Chancellor at Cardiff
University
Emmanuel Farber, M.D., Ph.D., Professor Emeritus, Department of
Pathology at the University of Toronto
Napoleone Ferrara, M.D., Ph.D., Distinguished Professor,
University of California,
San Diego
Isaiah J. Fidler, D.V.M., Ph.D., Head, Metastasis Research
Laboratory and R. E. "Bob" Smith Distinguished Chair in Cell
Biology, Department of Cancer Biology at the University of Texas MD
Anderson Cancer Center
Bernard Fisher, M.D., Distinguished Service Professor, Surgery
at the University of Pittsburgh
Joseph F. Fraumeni Jr., M.D., Senior Investigator and Advisor
to National Cancer Institute Division of Cancer Epidemiology &
Genetics, Office of the Director
Emil Frei III, M.D., Director and Physician-in-Chief Emeritus;
Richard and Susan Smith Distinguished Professor of Medicine, at
Dana-Farber Cancer Institute
Elaine V. Fuchs, Ph.D., Investigator, Laboratory of Mammalian
Cell Biology & Development at the Howard Hughes Medical
Institute at Rockefeller University
Judy E. Garber, M.D., M.P.H., Director, Center for Cancer
Genetics and Prevention at the Dana-Farber Cancer Institute
Walter Gilbert, Ph.D., Vice Chairman and Co-Founder at Paratek
Pharmaceuticals, Inc.
Alfred G. Gilman, M.D., Ph.D., Professor Emeritus, Department
of Pharmacology at the University of Texas Southwestern Medical
Center
Carol W. Greider, Ph.D., Director and Professor, Molecular
Biology & Genetics at Johns Hopkins University School of
Medicine
Roger C.L. Guillemin, M.D., Ph.D., Distinguished Professor at
the Salk Institute for Biological Studies
Sir John B. Gurdon, D.Phil., Distinguished Group Leader at The
Wellcome Trust/Cancer Research UK Gurdon Institute
William N. Hait, M.D., Ph.D., Global Head at Janssen Research
& Development, LLC, and Clinical Professor of Medicine,
UMDNJ-Robert Wood Johnson Medical School
Leland H. Hartwell, Ph.D., President & Director Emeritus,
Center for Sustainable Health Biodesign Institute at Arizona State
University
Avram Hershko, M.D., Ph.D., Distinguished Professor, Unit of
Biochemistry Technion-Israel Institute of Technology
James F. Holland, M.D., Distinguished Professor of Neoplastic
Disorders at the Icahn School of Medicine at Mount Sinai
Jimmie C. Holland, M.D., Wayne E. Chapman Chair in Psychiatric
Oncology; Attending Psychiatrist, Department of Psychiatry and
Behavioral Sciences at Memorial Sloan-Kettering Cancer Center
Waun Ki Hong, M.D., Professor and Head, Division of Cancer
Medicine at the University of Texas MD Anderson Cancer Center
Leroy E. Hood, M.D., Ph.D., President and Co-Founder of the
Institute for Systems Biology
H. Robert Horvitz, Ph.D., David H. Koch Professor of Biology at
the Massachusetts Institute of Technology
Susan Band Horwitz, Ph.D., Distinguished Professor and
Co-Chair, Department of Molecular Pharmacology at the Albert
Einstein College of Medicine of Yeshiva University
Sir R. Timothy Hunt, Ph.D., Emeritus Group Leader, ICRF Clare
Hall Laboratories at Cancer Research UK
Tony Hunter, Ph.D., Professor, Hunter Lab (MCBL-H) at the Salk
Institute for Biological Studies
Tyler Jacks, Ph.D., Director of the David H. Koch Institute for
Integrative Cancer Research at the Massachusetts Institute of
Technology
Peter A. Jones, Ph.D., D.Sc., Distinguished Professor of
Urology, Biochemistry and Molecular Biology at USC Norris
Comprehensive Cancer Center
V. Craig Jordan, Ph.D., D.Sc., Vice Chairman, Department of
Oncology Georgetown Lombardi Comprehensive Cancer Center
Yuet Wai Kan, M.D., Louis K. Diamond Professor of Hematology at
UCSF
Mary-Claire King, Ph.D., Professor, Division of Medical
Genetics at the University of Washington School of Medicine
Eva Klein, M.D., Ph.D., Professor Emeritus, Department of
Microbiology, Tumor and Cell Biology at Karolinska Institutet
George Klein, M.D., Ph.D., Professor Emeritus, Tumour Biology
at the Department of Microbiology, Tumor and Cell Biology at
Karolinska Institutet
Alfred G. Knudson Jr., M.D., Ph.D., Distinguished Scientist and
Senior Advisor to the President at Fox Chase Cancer Center
Brian K. Kobilka, M.D., Professor, Molecular and Cellular
Physiology at Stanford University School of Medicine
Margaret L. Kripke, Ph.D., Vivian L. Smith Distinguished Chair
and Professor in Immunology Emerita at the University of Texas MD
Anderson Cancer Center
Philip Leder, M.D., Professor Emeritus, Department of Genetics
at Harvard Medical School
Robert J. Lefkowitz, M.D., James B. Duke Professor of Medicine,
HHMI at Duke University Medical Center
Arnold J. Levine, Ph.D., Professor, Systems Biology at the
Institute for Advanced Study
Lawrence A. Loeb, M.D., Ph.D., Professor, Department of
Pathology at the University of Washington
Tak W. Mak, Ph.D., Director, Advanced Medical Discovery
Institute; Director, The Campbell Family Institute for Breast
Cancer Research; Senior Scientist, Division of Stem Cell and
Developmental Biology, Advanced Medical Discovery Institute/Ontario
Cancer Institute at the Campbell Family Institute for Breast Cancer
Research, Ontario Cancer Institute
Lynn M. Matrisian, Ph.D., Vice President, Scientific and
Medical Affairs at the Pancreatic Cancer Action Network
Frank McCormick, Ph.D., Director at the UCSF Helen Diller
Family Comprehensive Cancer Center
John Mendelsohn, M.D., Director, IPCT at the University of
Texas MD Anderson Cancer Center
Donald Metcalf, M.D., Professor Emeritus at the University of
Melbourne
Enrico Mihich, M.D., Presidential Scholar and Special Assistant
to the President for Sponsored Research at the Dana-Farber Cancer
Institute
Beatrice Mintz, Ph.D., Professor and Jack Schultz Chair in
Basic Research at Fox Chase Cancer Center
Luc Montagnier, M.D., Professor of Biology and Medicine at
Shanghai Jiao Tong University
Harold L. Moses, M.D., Hortense B. Ingram Professor of
Molecular Oncology; Professor and Acting Chair of Cancer Biology;
Professor of Medicine and Pathology, Microbiology and Immunology;
Director Emeritus at Vanderbilt-Ingram Comprehensive Cancer
Center
Sir Paul M. Nurse, Ph.D., President Emeritus; Professor,
Laboratory of Yeast Genetics and Cell Biology at The Rockefeller
University
Olufunmilayo I. Olopade, M.D., Walter L. Palmer Distinguished
Service Professor at the University of Chicago Medical Center
Arthur B. Pardee, Ph.D., Professor, Department of Biological
Chemistry and Molecular Pharmacology at Dana-Farber Cancer
Institute and Harvard Medical School
Martine J. Piccart, M.D., Ph.D., Head, Medicine Department at
the Institut Jules Bordet
Sir Bruce A.J. Ponder, Ph.D., Director at Cancer Research UK
Cambridge Research Institute
Sir Richard J. Roberts, Ph.D., Chief Scientific Officer at New
England Biolabs, Inc.
Irwin A. Rose, Ph.D., Distinguished Professor-Emeritus,
Department of Physiology & Biophysics at the University of
California at Irvine
Janet D. Rowley, M.D., Blum-Riese Distinguished Professor of
Medicine at the University of Chicago Medical Center
Frederick Sanger, Ph.D., Medical Research Council Laboratory of
Molecular Biology
Alan C. Sartorelli, Ph.D., Alfred Gilman Professor of
Pharmacology at Yale University School of Medicine; Department of
Pharmacology
Andrew V. Schally, PhD., Distinguished Medical Research
Scientist, Research at the University of Miami VA Medical
Center
Phillip A. Sharp, Ph.D., Institute Professor at the MIT Koch
Institute for Integrative Cancer Research
Charles J. Sherr, M.D., Ph.D., Investigator HHMI, Chairman of
Tumor Cell Biology at St. Jude Children's Research Hospital
Osamu Shimomura, Ph.D., Professor Emeritus at Boston University
School of
Medicine
Dennis J. Slamon, M.D., Ph.D., Director, Clinical/Translational
Research; Director, Revlon/UCLA Women's Cancer Research Program,
Jonsson Comprehensive Cancer Center; Professor of medicine; Chief
of the Division of Hematology/Oncology; Executive Vice Chair for
Research, Department of Medicine, University of California, Los
Angeles
Oliver Smithies, D. Phil., Weatherspoon Eminent Distinguished
Professor at the University of North Carolina at Chapel Hill
Michael B. Sporn, M.D., Professor of Pharmacology &
Medicine at Dartmouth Medical School
Louise C. Strong, M.D., Professor, Department of Genetics at
the University of Texas MD Anderson Cancer Center
Takashi Sugimura, M.D., Ph.D., Vice President at The Japan
Academy
Sir John E. Sulston, Ph.D., Professor and Chair of the
Institute for Science, Ethics and Innovation at the University of
Manchester
Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical
Institute, Massachusetts General Hospital
Roger Y. Tsien, Ph.D., Professor of Pharmacology and of
Chemistry & Biochemistry, the University of California,
San Diego
Arthur C. Upton, M.D., Clinical Professor of Environmental and
Occupational Medicine, UMDNJ-Robert Wood Johnson Medical
School
George F. Vande Woude, Ph.D., Distinguished Scientific Fellow
at Van Andel Research Institute
Bert Vogelstein, M.D., Professor of Oncology and Pathology,
Investigator, Howard Hughes Medical Institute at Johns Hopkins
Kimmel Comprehensive Cancer Center
Peter K. Vogt, Ph.D., Executive VP and CSO, The Scripps
Research Institute
Daniel D. Von Hoff, M.D., Physician-in-Chief,
Clinical Research at the Translational Genomics Research Institute
(TGen).
Geoffrey M. Wahl, Ph.D., Professor, Gene Expression Laboratory
at the The Salk Institute
James D. Watson, Ph.D., Chancellor Emeritus at the Cold Spring
Harbor Laboratory
Lee W. Wattenberg, M.D., Professor of Laboratory Medicine &
Pathology at the University of Minnesota
Robert A. Weinberg, Ph.D., Founding Member, Professor of
Biology at the MIT Whitehead Institute for Biomedical Research
John H. Weisburger, Ph.D., Consultant at Weisburger
Associates
Jane Cooke Wright, M.D., Deceased.
Shinya Yamanaka, M.D., Ph.D., Senior Investigator and the L.K.
Whittier Foundation Investigator in Stem Cell Biology at the
Gladstone Institutes; Professor of Anatomy, UCSF; Director, Center
for iPS Cell Research and Application (CiRA), Kyoto University;
Principal Investigator at the Institute for Integrated
Cell-Material Sciences, Kyoto
University
Harald zur Hausen, M.D., Professor Emeritus at the German
Cancer Research Center
# # #
Follow the AACR on Twitter: @aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer
Research
Founded in 1907, the American Association for Cancer Research
(AACR) is the world's first and largest professional organization
dedicated to advancing cancer research and its mission to prevent
and cure cancer. AACR membership includes more than 34,000
laboratory, translational and clinical researchers; population
scientists; other health care professionals; and cancer advocates
residing in more than 90 countries. The AACR marshals the full
spectrum of expertise of the cancer community to accelerate
progress in the prevention, biology, diagnosis and treatment of
cancer by annually convening more than 20 conferences and
educational workshops, the largest of which is the AACR Annual
Meeting with more than 17,000 attendees. In addition, the AACR
publishes eight peer-reviewed scientific journals and a magazine
for cancer survivors, patients and their caregivers. The AACR funds
meritorious research directly as well as in cooperation with
numerous cancer organizations. As the scientific partner of Stand
Up To Cancer, the AACR provides expert peer review, grants
administration and scientific oversight of team science and
individual grants in cancer research that have the potential for
near-term patient benefit. The AACR actively communicates with
legislators and policymakers about the value of cancer research and
related biomedical science in saving lives from cancer. For more
information about the AACR, visit www.AACR.org.
Media Contact:
Jeremy Moore
(215) 446-7109
Jeremy.Moore@aacr.org
*
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. For more
information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org